Mark John Alexander Webster

Gooch & Housego (UK) Ltd. engages in the manufacturing of optical and photographic instruments. The company was incorporated on July 28, 2006 and is headquartered in Illminster, the United Kingdom.

Part of Gooch & Housego Plc, Gooch & Housego Torquay Ltd. designs and manufactures electronic and fiber optic components and modules. The company is based in Illminster, UK.

Part of Gooch & Housego Plc, G & H US Holdings Ltd. functions as an investment holding British company. The company is based in Somerset, UK.

Founded in 1976, Spanoptic Ltd is one of the largest independent manufacturers of optical components in the United Kingdom. Based in Scotland, Spanoptic produces a broad range of custom designed optics made from various materials expanding from Ultraviolet to Infrared. With their experienced team and advanced technology they are able to produce precision optical components of superior quality at competitive price. They closely liaise with customers at all project levels and are aiming for absolute customer satisfaction. Spanoptic provides in-depth understanding of precision optics from design to fabrication with dedication to applications in the aerospace, security, defence, machine vision and health care & life science industry.

Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986